<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862735</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1018</article-id><article-id pub-id-type="other">EPV0277</article-id><article-id pub-id-type="pii">S0924933824010186</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Unraveling a Psychiatric Puzzle: Corticosteroid-Induced Psychosis in Addison&#x02019;s Disease. A case report</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Mayor Sanabria</surname><given-names>F.</given-names></name><xref rid="aff2310" ref-type="aff"/><xref rid="cor0874" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fern&#x000e1;ndez Fari&#x000f1;a</surname><given-names>M.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Exp&#x000f3;sito Dur&#x000e1;n</surname><given-names>M. E.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Regueiro Mart&#x000ed;n-Albo</surname><given-names>C. E.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Arroyo Del Val</surname><given-names>C.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Paz Otero</surname><given-names>M.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Alberdi P&#x000e1;ramo</surname><given-names>&#x000cd;.</given-names></name><xref rid="aff2310" ref-type="aff"/></contrib></contrib-group><aff id="aff2310"><institution>Instituto de Psiquiatr&#x000ed;a y Salud Mental, Hospital Cl&#x000ed;nico San Carlos</institution>, <city>Madrid</city>, <country>Spain</country></aff><author-notes><corresp id="cor0874"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="993">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S490</fpage><lpage>S490</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824010186a.pdf"/><abstract><sec id="sec5256"><title>Introduction</title><p>The spectrum of neuropsychiatric adverse effects of corticosteroids ranges from unspecific symptoms to structured psychotic or affective episodes. We present the case of a 30-year-old woman admitted to our hospital due to behavioral alterations, coinciding with the initiation of treatment with corticosteroid boluses as part of a chemotherapy regimen for gastric adenocarcinoma. She had a previous diagnose of Addison&#x02019;s disease, undergoing treatment with supplemental corticosteroids.</p></sec><sec id="sec5257"><title>Objectives</title><p><list list-type="order"><list-item><p>To describe the clinical particularities of this case, focusing on the psychopathological aspects and their correlation with the corticoid treatment.</p></list-item><list-item><p>To review the available literature regarding the clinical characteristics and management of corticosteroid-induced psychosis, with special interest in patients with adrenal insufficiency that require long term steroid supplementation.</p></list-item></list>
</p></sec><sec id="sec5258"><title>Methods</title><p>A review of the patient&#x02019;s clinical history and complementary tests were carried out. Likewise, we reviewed the available literature in relation to the clinical presentation of corticosteroid-induced psychosis and its pharmacological management.</p></sec><sec id="sec5259"><title>Results</title><p>The patient was admitted to our hospital due to acute behavioural alterations, which temporally coincided with the 4th cycle of FOLFOX chemotherapy and corticosteroid boluses. She presented with incoherent speech, with <italic toggle="yes">non sequitur</italic> answers and glossolalia, as well as dysphoric affect and purposeless behavior. She presented a favorable clinical course after the initiation of treatment with antipsychotics and temporary suspension of corticosteroid treatment.</p><p>Manic symptoms are the most common presentation of &#x0201c;corticosteroid-induced psychosis&#x0201d;, with the key characteristic being the temporal association with the corticosteroids administration. Although the discontinuation of steroids generally results in a sudden decrease in symptoms, additional treatment with antipsychotics such as haloperidol or olanzapine might be required for a symptomatic control. In patients with adrenal insufficiency, long-term treatment with lithium or anti-seizure treatments are effective strategies in relapse prevention when a higer steroid dose is required.</p></sec><sec id="sec5260"><title>Conclusions</title><p>
<list list-type="bullet"><list-item><p>Corticosteroid-induced psychosis is a well described clinical phenomenon, that usually presents with manic symptoms rather than psychotic experiences.</p></list-item><list-item><p>Progressive discontinuation of corticosteroid treatment usually results in complete cessation of symptoms, but additional psychopharmacological treatment might be required, especially in patients with adrenal insufficiency undergoing long-term corticosteroid treatment.</p></list-item><list-item><p>This case outlines the psychopathological richness in the presentation of corticosteroid-induced psychosis, and illustrates the challenges in the pharmacological management in patients with adrenal insufficiency.</p></list-item></list>
</p></sec><sec id="sec5261"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>